Acute Lymphoblastic Leukaemia Group

Research output

Research output per year 1997 2019 2020 2021 2022 2023 2024

• 67 Article
• 8 Letter
• 7 Review article
• 2 Editorial
• 1 More
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2024

  Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features

  Wechalekar, M. D., Zhao, L. P., Kutyna, M. M., Hong, L. E., Li, J., Hung, K., Scott, H. S., Brown, A., Hahn, C. C., Kassahn, K., Ladon, D., Yeung, D. T., Thomas, D., Patnaik, M., Proudman, S., Ades, L., Shah, M. V., Kok, C. H. & Hiwase, D. K., Dec 2024, In: Blood Cancer Journal. 14, 1, 116.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  File
  10 Downloads (Pure)
• 2023

  Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes

  Montarello, N., Leslie, A., Chhetri, R., Friel, O., Singhal, D., Ross, D., Yeung, D., Kok, C. H., Psaltis, P. J. & Hiwase, D. K., 11 Jul 2023, In: Blood Advances. 7, 13, p. 3032-3035 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
• 2022

  Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remission

  Lu, L., Kok, C. H., Dang, P., Branford, S., Saunders, V. A., Shanmuganathan, N., Ross, D. M., Hughes, T. P. & Yeung, D. T. O., Aug 2022, In: British Journal of Haematology. 198, 3, p. 600-603 4 p.

  Research output: Contribution to journal › Letter › peer-review
  3 Citations (Scopus)

• Monocytoid switch in an adult with B-cell precursor acute lymphoblastic leukaemia characterised by the PAX5 P80R mutation

  Mallik, S., Yeung, D., Rehn, J., Nguyen, T., Dunlop, L., Kwan, J. & White, D., Aug 2022, In: Pathology. 54, 5, p. 631-634 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Citation (Scopus)

• Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features

  McClure, B. J., Pal, M., Heatley, S. L., Rehn, J., Schutz, C., Breen, J., Venn, N. C., Sutton, R., Khaw, S. L., Yeung, D. T. & White, D. L., Mar 2022, In: British Journal of Haematology. 196, 6, p. 1407-1411 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  4 Citations (Scopus)
• 2020

  High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse

  McClure, B. J., Heatley, S. L., Rehn, J., Breen, J., Sutton, R., Hughes, T. P., Suppiah, R., Revesz, T., Osborn, M., White, D., Yeung, D. T. & White, D. L., 1 Oct 2020, In: British Journal of Haematology. 191, 2, p. 301-304 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Citations (Scopus)
• 2019

  Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

  Ross, D. M., Pagani, I. S., Irani, Y. D., Clarson, J., Leclercq, T., Dang, P., McLean, J., Saunders, V. A., Carne, L., Reynolds, J., Ritchie, D. S., White, D. L., Branford, S., Hughes, T. P. & Yong, A. S. M., Aug 2019, In: British Journal of Haematology. 186, 3, p. e56-e60

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  11 Citations (Scopus)

• Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission

  Shanmuganathan, N., Braley, J. A., Yong, A. S. M., Hiwase, D. K., Yeung, D. T., Ross, D. M., Hughes, T. P. & Branford, S., 4 Jul 2019, In: Blood. 134, 1, p. 85-89 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  24 Citations (Scopus)